Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide for relapse prevention in polymyalgia rheumatica during corticosteroid tapering
2017-001079-22Phase 3Active
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leflunomide in polymyalgia rheumatica (PMR), sponsored by University Medical Center Groningen. Started Jul 2024; status: active.
02
Drugs
leflunomide
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on 2017-001079-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001079-22.